CATO 佳途CATO · CNAS + ANAB ISO 17034 双体系认可标准物质生产者CNAS + ANAB ISO 17034 dual-accredited reference material producer
销售顾问Sales contact 卢振明Kaka Lu+86 185 2048 1969kaka@cato-chem.com
Glipizide

格列吡嗪 杂质对照品Glipizide Impurities

EP47 个杂质条目47 impurity entries

本页汇总 格列吡嗪 的 47 个杂质对照品条目,其中药典杂质标注了 EP/USP 编号。杂质谱是仿制药杂质研究、方法开发与稳定性考察的起点——先锁定品种,再逐条比对结构差异与保留行为。This page collects 47 impurity reference standards of Glipizide with EP/USP numbering where applicable. The impurity profile is the starting point for related-substance method development, forced degradation and stability studies.

批量索取报价 / COABulk quote / COA在全站目录中检索Search the full catalogue

相关研究文献Related literature

以下为 格列吡嗪(Glipizide)在公开文献中的研究报道(题录信息,来源 PubMed),供方法开发与文献调研参考。Selected peer-reviewed publications on this drug substance — bibliographic records from PubMed.

  1. 杂质研究Impurity studiesStability-indicating method development and validation for quantitative estimation of organic impurities of the antidiabetic drug glipizide in drug substance and pharmaceutical dosage form using HPLC
    Biomedical chromatography : BMC · 2023 · Nagulancha BR, Vandavasi KR  ·  PMID 37635093  ·  DOI
  2. 杂质研究Impurity studiesAnalytical Method Capable of Quantifying Eight Nitrosamine Impurities from Five Different Commercially Available Metformin Formulations with Glipizide, Glibenclamide, Gliclazide, Evogliptin, and Glimepiride by Ultra High Performance Liquid Chromatography Tripple Quadrupole Mass Spectrometry
    Journal of pharmaceutical sciences · 2023 · Solanki R et al.  ·  PMID 36822274  ·  DOI
  3. 杂质研究Impurity studiesValidated stability-indicating HPLC-UV method for simultaneous determination of glipizide and four impurities
    Journal of AOAC International · 2011 · Gupta S, Bansal G  ·  PMID 21563686
  4. 分析方法Analytical MethodsSimultaneous determination of glipizide and its four hydroxylated metabolites in human urine using LC-MS/MS and its application in urinary phenotype study
    Journal of pharmaceutical and biomedical analysis · 2017 · Tan B et al.  ·  PMID 28284082  ·  DOI

合成路线参考Reported synthetic routes

以下为公开文献中报道的合成方法(题录信息)。标题多已点明关键反应,可据此查阅原文了解完整路线与工艺条件。Published synthetic approaches. Titles usually name the key transformation; consult the original articles for full routes.

  • 合成方法SynthesisTotal Synthesis of Glipizide and Glibenclamide in Continuous Flow
    Chemistry (Weinheim an der Bergstrasse, Germany) · 2021 · Sagandira CR et al.  ·  PMID 34633700  ·  DOI

格列吡嗪 —— 原料药与杂质对照品Glipizide — drug substance & impurities

共 48 个条目(含原料药本体)48 items incl. the drug substance
Glipizide structure
EP原料药 APIAPI
格列吡嗪Glipizide
Glipizide
CAS No.29094-61-9
Chemical FormulaC21H27N5O4S
Purity>95%询价On request
10mg25mg50mg100mg
Glipizide Impurity 1(Glipizide EP Impurity A) structure
EPA
格列吡嗪杂质1(格列吡嗪EP杂质A)Glipizide Impurity 1(Glipizide EP Impurity A)
Glipizide Impurity 1(Glipizide EP Impurity A)
CAS No.33288-71-0
Chemical FormulaC14H16N4O3S
Purity>95%询价On request
10mg25mg50mg100mg
Glipizide Impurity 3(Glipizide EP Impurity C) structure
EPC
格列吡嗪杂质3(格列吡嗪EP杂质C)Glipizide Impurity 3(Glipizide EP Impurity C)
Glipizide Impurity 3(Glipizide EP Impurity C)
CAS No.13554-93-3
Chemical FormulaC18H27N3O5S
Purity>95%询价On request
10mg25mg50mg100mg
Glipizide Impurity 4(Glipizide EP Impurity D) structure
EPD
格列吡嗪杂质4(格列吡嗪EP杂质D)Glipizide Impurity 4(Glipizide EP Impurity D)
Glipizide Impurity 4(Glipizide EP Impurity D)
CAS No.1346600-54-1
Chemical FormulaC14H16N4O3S
Purity>95%询价On request
10mg25mg50mg100mg
Glipizide Impurity 5(Glipizide EP Impurity E) structure
EPE
格列吡嗪杂质5(格列吡嗪EP杂质E)Glipizide Impurity 5(Glipizide EP Impurity E)
Glipizide Impurity 5(Glipizide EP Impurity E)
CAS No.66375-96-0
Chemical FormulaC21H27N5O4S
Purity>95%询价On request
10mg25mg50mg100mg
Glipizide Impurity 6(Glipizide EP Impurity F) structure
EPF
格列吡嗪杂质6(格列吡嗪EP杂质F)Glipizide Impurity 6(Glipizide EP Impurity F)
Glipizide Impurity 6(Glipizide EP Impurity F)
CAS No.192118-08-4
Chemical FormulaC11H16N2O4S
Purity>95%询价On request
10mg25mg50mg100mg
Glipizide Impurity 7(Glipizide EP Impurity G) structure
EPG
格列吡嗪杂质7(格列吡嗪EP杂质G)Glipizide Impurity 7(Glipizide EP Impurity G)
Glipizide Impurity 7(Glipizide EP Impurity G)
CAS No.33288-74-3
Chemical FormulaC16H18N4O5S
Purity>95%询价On request
10mg25mg50mg100mg
Glipizide Impurity 8(Glipizide EP Impurity H) structure
EPH
格列吡嗪杂质8(格列吡嗪EP杂质H)Glipizide Impurity 8(Glipizide EP Impurity H)
Glipizide Impurity 8(Glipizide EP Impurity H)
CAS No.10080-05-4
Chemical FormulaC15H23N3O3S
Purity>95%询价On request
10mg25mg50mg100mg
Glipizide Impurity 9(Glipizide EP Impurity I) structure
EPI
格列吡嗪杂质9(格列吡嗪EP杂质I)Glipizide Impurity 9(Glipizide EP Impurity I)
Glipizide Impurity 9(Glipizide EP Impurity I)
CAS No.10079-35-3
Chemical FormulaC22H34N4O4S
Purity>95%询价On request
10mg25mg50mg100mg
Glipizide Impurity 13 structure
13
格列吡嗪杂质13Glipizide Impurity 13
Glipizide Impurity 13
CAS No.1076198-09-8
Chemical FormulaC17H20N4O5S
Purity>95%询价On request
10mg25mg50mg100mg
Glipizide Impurity 16 structure
16
格列吡嗪杂质16Glipizide Impurity 16
Glipizide Impurity 16
CAS No.877-95-2
Chemical FormulaC10H13NO
Purity>95%询价On request
10mg25mg50mg100mg
Glipizide Impurity 17 structure
17
格列吡嗪杂质17Glipizide Impurity 17
Glipizide Impurity 17
CAS No.41472-49-5
Chemical FormulaC10H14N2O3S
Purity>95%询价On request
10mg25mg50mg100mg
Glipizide Impurity 18 structure
18
格列吡嗪杂质18Glipizide Impurity 18
Glipizide Impurity 18
CAS No.35450-53-4
Chemical FormulaC10H12ClNO3S
Purity>95%询价On request
10mg25mg50mg100mg
Glipizide Impurity 23 Hydrochloride structure
23
格列吡嗪杂质23 盐酸盐Glipizide Impurity 23 Hydrochloride
Glipizide Impurity 23 Hydrochloride
CAS No.1428553-61-0
Chemical FormulaC15H23N3O3S·HCl
Purity>95%询价On request
10mg25mg50mg100mg
Glipizide Impurity 23 structure
23
格列吡嗪杂质23Glipizide Impurity 23
Glipizide Impurity 23
CAS No.2015-16-9
Chemical FormulaC15H23N3O3S
Purity>95%询价On request
10mg25mg50mg100mg
Glipizide Impurity 29 structure
29
格列吡嗪杂质29Glipizide Impurity 29
Glipizide Impurity 29
CAS No.947-92-2
Chemical FormulaC12H22N2O
Purity>95%询价On request
10mg25mg50mg100mg
Glipizide Impurity 30 structure
30
格列吡嗪杂质30Glipizide Impurity 30
Glipizide Impurity 30
CAS No.24683-00-9
Chemical FormulaC9H14N2O
Purity>95%询价On request
10mg25mg50mg100mg
Glipizide Impurity 31 structure
31
格列吡嗪杂质31Glipizide Impurity 31
Glipizide Impurity 31
CAS No.25773-40-4
Chemical FormulaC8H12N2O
Purity>95%询价On request
10mg25mg50mg100mg
Glipizide Impurity 32 structure
32
格列吡嗪杂质32Glipizide Impurity 32
Glipizide Impurity 32
CAS No.24168-70-5
Chemical FormulaC9H14N2O
Purity>95%询价On request
10mg25mg50mg100mg
Glipizide Impurity 34 structure
34
格列吡嗪杂质34Glipizide Impurity 34
Glipizide Impurity 34
CAS No.5521-61-9
Chemical FormulaC6H6N2O2
Purity>95%询价On request
10mg25mg50mg100mg
Glipizide Impurity 35 structure
35
格列吡嗪杂质35Glipizide Impurity 35
Glipizide Impurity 35
CAS No.1089523-59-0
Chemical FormulaC12H17N3O
Purity>95%询价On request
10mg25mg50mg100mg
Glipizide Impurity 36 structure
36
格列吡嗪杂质36Glipizide Impurity 36
Glipizide Impurity 36
CAS No.123-32-0
Chemical FormulaC6H8N2
Purity>95%询价On request
10mg25mg50mg100mg
Glipizide Impurity 39 structure
39
格列吡嗪杂质39Glipizide Impurity 39
Glipizide Impurity 39
CAS No.6303-75-9
Chemical FormulaC9H14N2
Purity>95%询价On request
10mg25mg50mg100mg
Glipizide Impurity 40 (N-Nitroso N-Phenethyl Acetamide) structure
40
格列吡嗪杂质40 (N-亚硝基 N-苯乙基乙酰胺)Glipizide Impurity 40 (N-Nitroso N-Phenethyl Acetamide)
Glipizide Impurity 40 (N-Nitroso N-Phenethyl Acetamide)
CAS No.14300-08-4
Chemical FormulaC10H12N2O2
Purity>95%询价On request
10mg25mg50mg100mg
Glipizide Impurity 41 structure
41
格列吡嗪杂质41Glipizide Impurity 41
Glipizide Impurity 41
CAS No.87885-45-8
Chemical FormulaC4H2ClN3O2
Purity>95%询价On request
10mg25mg50mg100mg
Glipizide Impurity 42 structure
42
格列吡嗪杂质42Glipizide Impurity 42
Glipizide Impurity 42
CAS No.1667725-52-1
Chemical FormulaC8H14N2
Purity>95%询价On request
10mg25mg50mg100mg
Glipizide Impurity 43 structure
43
格列吡嗪杂质43Glipizide Impurity 43
Glipizide Impurity 43
CAS No.35363-39-4
Chemical FormulaC6H12O3
Purity>95%询价On request
10mg25mg50mg100mg
Glipizide Impurity 47 structure
47
格列吡嗪杂质47Glipizide Impurity 47
Glipizide Impurity 47
CAS No.1121801-37-3
Chemical FormulaC22H34N4O4S
Purity>95%询价On request
10mg25mg50mg100mg
Glipizide Impurity 55 structure
55
格列吡嗪杂质55Glipizide Impurity 55
Glipizide Impurity 55
CAS No.33332-28-4
Chemical FormulaC4H4ClN3
Purity>95%询价On request
10mg25mg50mg100mg
Glipizide Impurity 56 structure
56
格列吡嗪杂质56Glipizide Impurity 56
Glipizide Impurity 56
CAS No.2321126-60-5
Chemical FormulaC22H24N4O7S
Purity>95%询价On request
10mg25mg50mg100mg
Glipizide Impurity 57 structure
57
格列吡嗪杂质57Glipizide Impurity 57
Glipizide Impurity 57
CAS No.2314312-87-1
Chemical FormulaC20H22N4O8S
Purity>95%询价On request
10mg25mg50mg100mg
Glipizide Impurity 58 structure
58
格列吡嗪杂质58Glipizide Impurity 58
Glipizide Impurity 58
CAS No.2317934-61-3
Chemical FormulaC25H23N3O8S
Purity>95%询价On request
10mg25mg50mg100mg
Glipizide Impurity 59 structure
59
格列吡嗪杂质59Glipizide Impurity 59
Glipizide Impurity 59
CAS No.2317876-72-3
Chemical FormulaC24H26N4O8S
Purity>95%询价On request
10mg25mg50mg100mg
Glipizide Impurity 60 structure
60
格列吡嗪杂质60Glipizide Impurity 60
Glipizide Impurity 60
CAS No.5910-89-4
Chemical FormulaC6H8N2
Purity>95%询价On request
10mg25mg50mg100mg
Glipizide Impurity 61 structure
61
格列吡嗪杂质61Glipizide Impurity 61
Glipizide Impurity 61
CAS No.5531-33-9
Chemical FormulaC12H17NO
Purity>95%询价On request
10mg25mg50mg100mg
Glipizide Impurity 62 structure
62
格列吡嗪杂质62Glipizide Impurity 62
Glipizide Impurity 62
CAS No.75907-74-3
Chemical FormulaC8H12N2O
Purity>95%询价On request
10mg25mg50mg100mg
Glipizide Impurity 63 structure
63
格列吡嗪杂质63Glipizide Impurity 63
Glipizide Impurity 63
CAS No.58202-95-2
Chemical FormulaC10H19NO2
Purity>95%询价On request
10mg25mg50mg100mg
Glipizide Impurity 65 structure
65
格列吡嗪杂质65Glipizide Impurity 65
Glipizide Impurity 65
CAS No.1378839-68-9
Chemical FormulaC6H6N2O3
Purity>95%询价On request
10mg25mg50mg100mg
Glipizide Impurity 66 structure
66
格列吡嗪杂质66Glipizide Impurity 66
Glipizide Impurity 66
CAS No.61892-95-3
Chemical FormulaC6H8N2O
Purity>95%询价On request
10mg25mg50mg100mg
Glipizide Impurity 67 structure
67
格列吡嗪杂质67Glipizide Impurity 67
Glipizide Impurity 67
CAS No.50866-30-3
Chemical FormulaC6H6N2O
Purity>95%询价On request
10mg25mg50mg100mg
Glipizide Impurity 68 Sodium Salt structure
68
格列吡嗪杂质68 钠盐Glipizide Impurity 68 Sodium Salt
Glipizide Impurity 68 Sodium Salt
CAS No.1350513-48-2
Chemical FormulaC8H10NO3S-·Na+
Purity>95%询价On request
10mg25mg50mg100mg
Glipizide Impurity 68 structure
68
格列吡嗪杂质68Glipizide Impurity 68
Glipizide Impurity 68
CAS No.33048-01-0
Chemical FormulaC8H11NO3S
Purity>95%询价On request
10mg25mg50mg100mg
Glipizide Impurity 70 structure
70
格列吡嗪杂质70Glipizide Impurity 70
Glipizide Impurity 70
CAS No.73631-60-4
Chemical FormulaC8H11NO6S2
Purity>95%询价On request
10mg25mg50mg100mg
Glipizide Impurity 71 structure
71
格列吡嗪杂质71Glipizide Impurity 71
Glipizide Impurity 71
CAS No.4363-92-2
Chemical FormulaC7H12ClNO
Purity>95%询价On request
10mg25mg50mg100mg
Glipizide Impurity 72 structure
72
格列吡嗪杂质72Glipizide Impurity 72
Glipizide Impurity 72
CAS No.2200019-24-3
Chemical FormulaC11H16N2O4S
Purity>95%询价On request
10mg25mg50mg100mg
Glipizide Impurity 73 structure
73
格列吡嗪杂质73Glipizide Impurity 73
Glipizide Impurity 73
CAS No.2203391-48-2
Chemical FormulaC17H22N4O5S2
Purity>95%询价On request
10mg25mg50mg100mg
Glipizide Impurity 75 structure
75
格列吡嗪杂质75Glipizide Impurity 75
Glipizide Impurity 75
CAS No.1638334-24-3
Chemical FormulaC9H10N2O4
Purity>95%询价On request
10mg25mg50mg100mg
Glipizide Impurity 79 structure
79
格列吡嗪杂质79Glipizide Impurity 79
Glipizide Impurity 79
CAS No.29906-92-1
Chemical FormulaC8H14N2
Purity>95%询价On request
10mg25mg50mg100mg
本品种含亚硝胺类杂质条目。亚硝胺杂质属于 ICH M7 关注的潜在致突变杂质,建议在方法开发中纳入专属性考察。This list includes nitrosamine entries. Nitrosamines are potential mutagenic impurities under ICH M7 and should be covered by a specific method.

结构式清晰度以随货 COA 与厂家图谱为准;目录之外的杂质可按需定制合成或调取。Structural confirmation is governed by the COA and manufacturer spectra. Impurities outside this list can be custom-synthesised or sourced on request.

Literature & synthesis

格列吡嗪 —— 研究文献与合成路线Glipizide — literature & synthetic routes

以下题录由公开学术数据库按品种名检索汇总,供 格列吡嗪 的杂质谱研究、分析方法开发与工艺路线选择参考。文献题名与专利标题均可点击查看原文,版权归原作者与出版方所有。Citations below are aggregated from public scholarly databases by drug-substance name, for reference in impurity profiling, analytical method development and route selection for Glipizide. Titles link to the original records; copyright remains with the authors and publishers.

杂质与降解研究文献Impurity & degradation studies

  1. LC and LC-MS study on establishment of degradation pathway of glipizide under forced decomposition conditions
    Bansal G, Singh M, Jindal KC, et al. · Journal of chromatographic science · 2008 · 被引 7cited 7
  2. Stability-indicating method development and validation for quantitative estimation of organic impurities of the antidiabetic drug glipizide in drug substance and pharmaceutical dosage form using HPLC
    Nagulancha BR, Vandavasi KR · Biomedical chromatography : BMC · 2023 · 被引 1cited 1
  3. Validated stability-indicating HPLC-UV method for simultaneous determination of glipizide and four impurities
    Gupta S, Bansal G · Journal of AOAC International · 2011 · 被引 3cited 3
  4. Analytical Method Capable of Quantifying Eight Nitrosamine Impurities from Five Different Commercially Available Metformin Formulations with Glipizide, Glibenclamide, Gliclazide, Evogliptin, and Glimepiride by Ultra High Performance Liquid Chromatography Tripple Quadrupole Mass Spectrometry
    Solanki R, Wadhwana P, Patel R, et al. · Journal of pharmaceutical sciences · 2023 · 被引 6cited 6
  5. Simultaneous Determination of Metformin, Glipizide, Repaglinide, and Glimepiride or Metformin and Pioglitazone by a Validated LC Method: Application in the Presence of Metformin Impurity (1-Cyanoguanidine)
    El-Zaher AA, Elkady EF, Elwy HM, et al. · Journal of AOAC International · 2016 · 被引 8cited 8
  6. Spectrophotometric Determination of Metformin in Different Pharmaceutical Combinations With Glipizide or Sitagliptin in Presence of Toxic Impurities of Metformin
    Abdallah FF, Magdy F, Abdelaleem EA, et al. · Journal of AOAC International · 2022 · 被引 4cited 4

合成与制备工艺专利Synthesis & process patents

  1. Glipizide calcium alginate gel rubber pellet and preparation method thereof
    QINENG PING, WENYUAN FAN, YANYU XIAO, WENLI LU, et al. · 公开号 CN101313892CN101313892 · 2008
  2. Metformin hydrochloride and Glipizide sustained-release pellet and method of preparing the same
    QINENG PING, WENYUAN FAN, YANYU XIAO, WENLI LU, et al. · 公开号 CN101278919CN101278919 · 2008
  3. Slow-releasing preparation containing metformin hydrochloride and glipizide and its preparation method
    LIU JICHENG NIU · 公开号 CN101057849CN101057849 · 2007
  4. Sustained release preparation of glipizide/metformin hydrochloride and its preparation method
    LIANG GUODONG, ZHANG GANG, YANG DONGYUN · 公开号 CN1602873CN1602873 · 2005
  5. Slow controlled released combsn. preparation of semisolid framework of containing glipizide
    GU LINJIN ZHAO · 公开号 CN1695622CN1695622 · 2005

题录与链接来自公开数据库 Europe PMC(含 PubMed 与全球专利题录)与 WIPO PatentScope,本站仅提供索引,不转载正文;如链接失效请以数据库检索为准。Citations are indexed from public databases (Europe PMC incl. PubMed and patent records, WIPO PatentScope); we provide links only and do not reproduce full text.

For formulation & analytical R&D

格列吡嗪 杂质谱研究要点Glipizide — impurity profiling notes

下面这些是拿到 格列吡嗪 的 48 个杂质条目之后,仿制药研发最常遇到的几件事。先把杂质的来源分清,再决定要不要买对照品、买哪几个。Once you have the 48 impurity entries for Glipizide, these are the questions that come up most in generic development. Classify the source of each impurity first, then decide which reference standards you actually need.

01工艺杂质Process impurities

起始物料、中间体、副产物、催化剂与溶剂残留。多来自合成路线本身,应在工艺开发阶段用加标试验定位。Starting materials, intermediates, by-products, catalysts and residual solvents — traced back to the synthetic route and located with spiking studies during process development.

02降解杂质Degradation impurities

水解、氧化、光解、高温高湿与聚合产物。需通过强制降解试验识别,并确认方法具备稳定性指示能力。Hydrolytic, oxidative, photolytic, thermal and polymeric degradants — identified through forced degradation, with the method proven stability-indicating.

03药典杂质Pharmacopoeial impurities

EP/USP 已收载并有官方编号的杂质(如 EP Impurity A、USP Related Compound B)。申报时通常需逐项对照。Impurities already monographed with official designations (e.g. EP Impurity A, USP Related Compound B), normally compared item by item during filing.

04基因毒性杂质Genotoxic impurities

含警示结构、需按 ICH M7 进行危害评估与限度推导(TTC 1.5 µg/日)。该类杂质必须用对照品准确控制。Structurally alerting compounds requiring ICH M7 hazard assessment and limit derivation (TTC 1.5 µg/day); these must be controlled with an authentic reference standard.

05同位素标记物Isotopically labelled standards

氘代、¹³C、¹⁵N 标记的同类物,主要用作 LC-MS/MS 生物分析的内标,抵消基质效应与回收率波动。Deuterated, ¹³C- and ¹⁵N-labelled analogues used as internal standards in LC-MS/MS bioanalysis to compensate matrix effects and recovery variation.

06代谢与转化产物Metabolites & conversion products

体内代谢物、强制降解转化物与工艺中间态,常见于杂质谱比对与稳定性考察中。In-vivo metabolites, forced-degradation products and process intermediates encountered in impurity profiling and stability studies.

本品种含药典编号杂质(EP/USP)。申报时药典已收载的杂质通常需要逐项对照,建议优先备齐药典编号对照品,再补充工艺与降解杂质。This drug substance includes pharmacopoeially designated impurities (EP/USP). Monographed impurities normally need item-by-item comparison during filing, so secure the pharmacopoeial standards first, then fill in process and degradation impurities.

方法开发与对照品使用建议Method development and standards usage

先定分离,再谈定量Resolution first, then quantification

主成分与相邻杂质峰分离度应 ≥1.5;用杂质对照品确定相对保留时间与相对响应因子,避免用自身对照法掩盖响应差异。Target baseline resolution ≥1.5 between the main component and adjacent impurities; establish relative retention and relative response factors with authentic impurity standards rather than relying on self-comparison.

校正因子不可忽略Never ignore response factors

紫外吸收差异大的杂质必须校正,否则定量结果系统性偏低或偏高。EP/USP 已给出校正因子的按药典执行。Impurities with markedly different UV response need correction, otherwise results are systematically biased. Where EP/USP publish a correction factor, follow the monograph.

强制降解要做全Run the full forced-degradation panel

建议覆盖酸、碱、氧化(H₂O₂)、光照(ICH Q1B)、高温高湿;主峰纯度用二极管阵列或质谱确认。Cover acid, base, peroxide oxidation, photostability (ICH Q1B) and heat/humidity; confirm peak purity by DAD or MS.

定义报告阈值Set reporting and identification thresholds

按 ICH Q3A/Q3B 设定报告阈值、鉴定阈值与界定阈值,避免为无意义的峰投入过多工作量。Apply ICH Q3A/Q3B reporting, identification and qualification thresholds so effort is not spent on insignificant peaks.

标准品储存有讲究Store standards properly

杂质对照品多建议 −20 ℃ 避光、干燥、密封保存;溶液现配现用,并记录开瓶与配制日期。Most impurity standards should be stored at −20 °C, protected from light and moisture; prepare solutions fresh and record opening and preparation dates.

用结构式先做初判Start from the structure

先比对杂质与主成分的结构差异,可预判其保留行为、紫外响应与可能的降解路径,能显著减少试错。Comparing the impurity structure with the parent drug predicts retention behaviour, UV response and probable degradation routes, cutting trial and error.

以上为通行的杂质研究实践提示,不针对具体品种给出结论。实际限度、校正因子与色谱条件请以 EP/USP 各论及你们的验证数据为准。需要某个杂质的结构确证资料、COA 或定制合成,可直接联系我们。The above are general impurity-profiling notes and are not conclusions about this specific drug substance. Actual limits, correction factors and chromatographic conditions follow the EP/USP monograph and your own validation data. Contact us for structural confirmation data, COAs or custom synthesis.
索取杂质谱报价 / COARequest a quote / COA← 查看其它品种← Other drug substances